KEYNOTE-061: Phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer

التفاصيل البيبلوغرافية
العنوان: KEYNOTE-061: Phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer
المؤلفون: Min-Hee Ryu, Christian Caglevic, Soonmo Peter Kang, Wasat Mansoor, M. Di Bartolomeo, Raymond S. McDermott, X. Chen, H.C. Chung, E. Schacham-Shmueli, Kohei Shitara, Kei Muro, Y-J. Bang, Mario Mandalà, A. Ohtsu, Tomasz Olesinski, Mustafa Ozguroglu, E. Gökkurt, Carlos Alberto Mayo, Lorenzo Fornaro, Charles S. Fuchs
المصدر: Annals of Oncology. 29:v123
بيانات النشر: Elsevier BV, 2018.
سنة النشر: 2018
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, business.industry, Phases of clinical research, Cancer, Hematology, Pembrolizumab, Gastroesophageal Junction, medicine.disease, 03 medical and health sciences, chemistry.chemical_compound, 030104 developmental biology, 0302 clinical medicine, Paclitaxel, chemistry, 030220 oncology & carcinogenesis, Internal medicine, Medicine, business, Previously treated
تدمد: 0923-7534
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b7525be3df7f9fb6fb7aefe7dee9e6d8Test
https://doi.org/10.1093/annonc/mdy208.004Test
حقوق: OPEN
رقم الانضمام: edsair.doi...........b7525be3df7f9fb6fb7aefe7dee9e6d8
قاعدة البيانات: OpenAIRE